146 related articles for article (PubMed ID: 35427748)
1. Studying the effect of drug-to-excipient ratio on drug release profile for drug coated balloons.
Woolford S; Tran M; Yoda C; Oktem B; NguyenPho A; McDermott M; Wickramasekara S
Int J Pharm; 2022 May; 620():121749. PubMed ID: 35427748
[TBL] [Abstract][Full Text] [Related]
2. Development of an automated micropipette coating method for drug-coated balloons.
Fuglsby K; Anderson JA; Engebretson D; Lamichhane S
J Biomed Mater Res B Appl Biomater; 2020 Jul; 108(5):2258-2275. PubMed ID: 31967398
[TBL] [Abstract][Full Text] [Related]
3. Optimization of balloon coating process for paclitaxel coated balloons via micro-pipetting method.
Woolford SE; Tran M; NguyenPho A; McDermott MK; Oktem B; Wickramasekara S
Int J Pharm; 2019 Jan; 554():312-321. PubMed ID: 30395954
[TBL] [Abstract][Full Text] [Related]
4. Coating and Pharmacokinetic Evaluation of Air Spray Coated Drug Coated Balloons.
Turner EA; Atigh MK; Erwin MM; Christians U; Yazdani SK
Cardiovasc Eng Technol; 2018 Jun; 9(2):240-250. PubMed ID: 29497966
[TBL] [Abstract][Full Text] [Related]
5. In vitro evaluation of paclitaxel coatings for delivery via drug-coated balloons.
Kempin W; Kaule S; Reske T; Grabow N; Petersen S; Nagel S; Schmitz KP; Weitschies W; Seidlitz A
Eur J Pharm Biopharm; 2015 Oct; 96():322-8. PubMed ID: 26318979
[TBL] [Abstract][Full Text] [Related]
6. Intrinsic coating morphology modulates acute drug transfer in drug-coated balloon therapy.
Chang GH; Azar DA; Lyle C; Chitalia VC; Shazly T; Kolachalama VB
Sci Rep; 2019 May; 9(1):6839. PubMed ID: 31048704
[TBL] [Abstract][Full Text] [Related]
7. Pre-Clinical Investigation of Keratose as an Excipient of Drug Coated Balloons.
Goel E; Erwin M; Cawthon CV; Schaff C; Fedor N; Rayl T; Wilson O; Christians U; Register TC; Geary RL; Saul J; Yazdani SK
Molecules; 2020 Mar; 25(7):. PubMed ID: 32244375
[TBL] [Abstract][Full Text] [Related]
8.
Turner E; Erwin M; Atigh M; Christians U; Saul JM; Yazdani SK
Front Pharmacol; 2018; 9():808. PubMed ID: 30104972
[No Abstract] [Full Text] [Related]
9. Hydrophilic Coating Microstructure Mediates Acute Drug Transfer in Drug-Coated Balloon Therapy.
Shazly T; Eberth JF; Kostelnik CJ; Uline MJ; Chitalia VC; Spinale FG; Alshareef A; Kolachalama VB
ACS Appl Bio Mater; 2024 May; 7(5):3041-3049. PubMed ID: 38661721
[TBL] [Abstract][Full Text] [Related]
10. Novel paclitaxel-coated angioplasty balloon catheter based on cetylpyridinium salicylate: preparation, characterization and simulated use in an in vitro vessel model.
Petersen S; Kaule S; Stein F; Minrath I; Schmitz KP; Kragl U; Sternberg K
Mater Sci Eng C Mater Biol Appl; 2013 Oct; 33(7):4244-50. PubMed ID: 23910339
[TBL] [Abstract][Full Text] [Related]
11. Correlating coating characteristics with the performance of drug-coated balloons--a comparative in vitro investigation of own established hydrogel- and ionic liquid-based coating matrices.
Kaule S; Minrath I; Stein F; Kragl U; Schmidt W; Schmitz KP; Sternberg K; Petersen S
PLoS One; 2015; 10(3):e0116080. PubMed ID: 25734818
[TBL] [Abstract][Full Text] [Related]
12. A novel paclitaxel coated balloon with increased drug transfer for treatment of complex vascular lesions.
Gemeinhardt O; Schnorr B; Speck U; Scheller B
PLoS One; 2021; 16(10):e0259106. PubMed ID: 34714843
[TBL] [Abstract][Full Text] [Related]
13. Dextran sulfate as a drug delivery platform for drug-coated balloons: Preparation, characterization, in vitro drug elution, and smooth muscle cell response.
Lamichhane S; Anderson J; Remund T; Kelly P; Mani G
J Biomed Mater Res B Appl Biomater; 2016 Oct; 104(7):1416-30. PubMed ID: 26227252
[TBL] [Abstract][Full Text] [Related]
14. Stellarex drug-coated balloon: a technology evaluation.
Nerla R; Castriota F; Cremonesi A; Micari A
Expert Opin Drug Deliv; 2020 Sep; 17(9):1181-1188. PubMed ID: 32615811
[TBL] [Abstract][Full Text] [Related]
15. Development of drug-coated balloon for the treatment of multiple peripheral artery segments.
Anderson JA; Lamichhane S; Fuglsby K; Remund T; Pohlson K; Evans R; Engebretson D; Kelly P
J Vasc Surg; 2020 May; 71(5):1750-1757.e7. PubMed ID: 31519510
[TBL] [Abstract][Full Text] [Related]
16. Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: Twelve-Month Outcomes From the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies.
Krishnan P; Faries P; Niazi K; Jain A; Sachar R; Bachinsky WB; Cardenas J; Werner M; Brodmann M; Mustapha JA; Mena-Hurtado C; Jaff MR; Holden AH; Lyden SP
Circulation; 2017 Sep; 136(12):1102-1113. PubMed ID: 28729250
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound controlled paclitaxel releasing system-A novel method for improving the availability of coronary artery drug coated balloon.
Song C; Zhou C; Zhang J; Feng X; Cui X; Zhang F; Ma J; Toft ES; Ge J; Zhang H
Catheter Cardiovasc Interv; 2020 Aug; 96(2):E119-E128. PubMed ID: 31659805
[TBL] [Abstract][Full Text] [Related]
18. Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease.
Ouriel K; Adelman MA; Rosenfield K; Scheinert D; Brodmann M; Peña C; Geraghty P; Lee A; White R; Clair DG
JACC Cardiovasc Interv; 2019 Dec; 12(24):2515-2524. PubMed ID: 31575518
[TBL] [Abstract][Full Text] [Related]
19. Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipients.
Radke PW; Joner M; Joost A; Byrne RA; Hartwig S; Bayer G; Steigerwald K; Wittchow E
EuroIntervention; 2011 Oct; 7(6):730-7. PubMed ID: 21986331
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic Evaluation of Two Paclitaxel-Coated Balloons with Different Drug Load in a Short-Term Porcine Study.
Abadal JM; Vazquez E; Morales M; Toro A; Quintana M; Araujo M
Cardiovasc Intervent Radiol; 2016 Aug; 39(8):1152-8. PubMed ID: 27094691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
